3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, also known as statins, are the first-line drugs used for the prevention and treatment of cardiovascular diseases (36, 37). Here, HMGCR is linked to cardiovascular disorder.